Table 2

Characteristics of patients with isolated traumatic brain injury aged ≥60 years, stratified by receipt of ICP monitoring (n=2303)

ICP, n=66No ICP, n=2237P value*
Age in years, mean (SD)72.2 (8.4)77.1 (9.1)<0.001
Age categories, n (%)0.001
 60–8155 (83.3)1399 (62.5)
 >8111 (16.7)838 (37.5)
 Sex, n (%)0.02
 Female24 (36.4)1129 (50.5)
 Male42 (63.6)1108 (49.5)
Race, n (%)0.03
 White45 (68.2)1809 (80.9)
 Black9 (13.6)166 (7.4)
 Other12 (18.2)262 (11.7)
Comorbidities, n (%)
 Neurological19 (35.2)890 (40.9)0.39
 Cardiac disease44 (81.5)1873 (86.3)0.31
 Respiratory disease9 (16.7)466 (21.5)0.40
 Kidney disease10 (18.5)347 (15.9)0.62
 Liver disease4 (7.4)119 (5.5)0.54
 Anticoagulants at home, n (%)10 (15.2)445 (19.9)0.34
 Warfarin7 (10.6)233 (10.4)0.96
 Direct oral anticoagulants3 (7.0)205 (10.0)0.51
 Antiplatelet use at home, n (%)22 (33.3)1059 (47.3)0.03
Cause of injury, n (%)<0.001
 Motor vehicle collision14 (21.2)176 (7.9)
 Fall46 (69.7)1967 (88.4)
 Assault5 (7.6)34 (1.5)
 Other1 (1.5)47 (2.1)
Head AIS score, n (%)<0.001
 24 (6.1)507 (22.7)
 38 (12.1)882 (39.4)
 415 (22.7)488 (21.8)
 539 (59.1)349 (15.6)
 6011 (<1)
GCS score†, n (%)<0.001
 13–1511 (16.7)1914 (85.6)
 9–1212 (18.2)126 (5.6)
 <943 (65.2)197 (8.8)
Initial CT results, n (%)
 Subdural hematoma54 (81.8)1462 (65.4)0.01
 Epidural hematoma5 (7.6)56 (2.5)0.01
 Intraventricular hemorrhage16 (24.2)163 (7.3)<0.001
 Subarachnoid hemorrhage45 (68.2)1089 (48.7)0.002
 Intraparenchymal hemorrhage26 (39.4)371 (16.6)<0.001
 Cerebral edema9 (13.6)74 (3.3)<0.001
 Skull fracture29 (43.9)195 (8.7)<0.001
 CT worsening (any), n (%)45 (68.2)520 (23.3)<0.001
Pupil reactivity, n (%)<0.001
 Both45 (68.2)2110 (94.3)
 One8 (12.1)43 (1.9)
 Neither13 (19.7)84 (3.8)
 Neurosurgical intervention, n (%)31 (47.0)178 (8.0)<0.001
 Craniotomy20 (30.3)128 (5.7)<0.001
 Craniectomy10 (15.2)30 (1.3)<0.001
 Tracheostomy, n (%)17 (25.8)40 (1.8)<0.001
 PEG tube/gastrostomy, n (%)21 (31.8)73 (3.3)<0.001
 Laboratory values, n (%)
 INR ≥2
58 (92.1)1814 (91.9)0.96
 Platelet transfusions, n (%)15 (22.7)245 (10.9)0.003
Reversal agents administered, n (%)
 Vitamin K7 (10.6)157 (7.0)0.26
 Fresh frozen plasma8 (12.1)87 (3.9)0.001
 Three-factor prothrombin complex concentrate1 (1.5)25 (1.1)0.76
 Length of hospital stay in days, median (IQR)14 (16)4 (5)<0.001
 Length of ICU stay in days, median (IQR)12 (10)2 (3)<0.001
 Ventilator days, median (IQR)6 (9)3 (7)<0.001
 Palliative interventions, n (%)31 (47.7)310 (13.9)<0.001
 Do not attempt resuscitation, n (%)18 (27.3)191 (8.5)<0.001
  Days from admission, median (IQR)5 (3–8)1 (1–4)0.004
 Palliative care consult, n (%)11 (16.7)128 (5.7)<0.001
  Days from admission, median (IQR)6 (2–10)2 (1–6)0.19
 Discontinuation of life-sustaining measures, n (%)19 (28.8)126 (5.6)<0.001
  Days from admission, median (IQR)5 (4–14)3 (1–7)0.008
 Hospice care, n (%)1 (1.5)100 (4.5)0.25
  Days from admission, median (IQR)35 (2–8.5)0.67
 Death at discharge, n (%)31 (46.9)209 (9.3)<0.001
 Change in residence, n (%)<0.001
 More care required/deceased59 (89.4)993 (44.4)
  • *P value comparing across age categories from Student’s t-test, Wilcoxon rank-sum, or χ2 goodness of fit.

  • †Best postresuscitation GCS score.

  • AIS, Abbreviated Injury Scale; GCS, Glasgow Coma Scale; ICP, intracranial pressure; ICU, intensive care unit; INR, international normalized ratio; PEG, percutaneous endoscopic gastrostomy.